Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection

被引:51
作者
Kao, S
Akari, H
Khan, MA
Dettenhofer, M
Yu, XF
Strebel, M
机构
[1] NIAID, NIH, Mol Microbiol Lab, Viral Biochem Sect, Bethesda, MD 20892 USA
[2] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
关键词
D O I
10.1128/JVI.77.2.1131-1140.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Packaging of the human immunodeficiency virus type I Vif protein into virus particles is mediated through an interaction with viral genomic RNA and results in the association of Vif with the nucleoprotein complex. Despite the specificity of this process, calculations of the amount of Vif packaged have produced vastly different results. Here, we compared the efficiency of packaging of Vif into virions derived from acutely and chronically infected H9 cells. We found that Vif was efficiently packaged into virions from acutely infected cells (60 to 100 copies per virion), while packaging into virions from chronically infected H9 cells was near the limit of detection (four to six copies of Vif per virion). Superinfection by an exogenous Vif-defective virus did not rescue packaging of endogenous Vif expressed in the chronically infected culture. In contrast, exogenous Vif expressed by superinfection of wild-type virus was readily packaged (30 to 40 copies per virion). Biochemical analyses suggest that the differences in the relative packaging efficiencies were not due to gross differences in the steady-state distribution of Vif in chronically or acutely infected cells but are likely due to differences in the relative rates of de novo synthesis of Vif, Despite its low packaging efficiency, endogenously expressed Vif was sufficient to direct the production of viruses with almost wild-type infectivity. The results from our study provide novel insights into the biochemical properties of Vif and offer an explanation for the reported differences regarding Vif packaging.
引用
收藏
页码:1131 / 1140
页数:10
相关论文
共 58 条
  • [1] PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE
    ADACHI, A
    GENDELMAN, HE
    KOENIG, S
    FOLKS, T
    WILLEY, R
    RABSON, A
    MARTIN, MA
    [J]. JOURNAL OF VIROLOGY, 1986, 59 (02) : 284 - 291
  • [2] BIOLOGICAL CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 MUTANTS IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    AKARI, H
    SAKURAGI, J
    TAKEBE, Y
    TOMONAGA, K
    KAWAMURA, M
    FUKASAWA, M
    MIURA, T
    SHINJO, T
    HAYAMI, M
    [J]. ARCHIVES OF VIROLOGY, 1992, 123 (1-2) : 157 - 167
  • [3] Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: functional difference between Vif and Nef
    Akari, H
    Uchiyama, T
    Fukumori, T
    Iida, S
    Koyama, AH
    Adachi, A
    [J]. JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 2945 - 2949
  • [4] TIGHTLY BOUND ZINC IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I, AND OTHER RETROVIRUSES
    BESS, JW
    POWELL, PJ
    ISSAQ, HJ
    SCHUMACK, LJ
    GRIMES, MK
    HENDERSON, LE
    ARTHUR, LO
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (02) : 840 - 847
  • [5] TRANSCOMPLEMENTATION OF VIF- HIV-1 MUTANTS IN CEM CELLS SUGGESTS THAT VIF AFFECTS LATE STEPS OF THE VIRAL LIFE-CYCLE
    BLANC, D
    PATIENCE, C
    SCHULZ, TF
    WEISS, R
    SPIRE, B
    [J]. VIROLOGY, 1993, 193 (01) : 186 - 192
  • [6] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY
    BORMAN, AM
    QUILLENT, C
    CHARNEAU, P
    DAUGUET, C
    CLAVEL, F
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2058 - 2067
  • [7] Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells
    Bouyac, M
    Rey, F
    Nascimbeni, M
    Courcoul, M
    Sire, J
    Blanc, D
    Clavel, F
    Vigne, R
    Spire, B
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (03) : 2473 - 2477
  • [8] Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor
    Bouyac, M
    Courcoul, M
    Bertola, G
    Baudat, Y
    Gabuzda, D
    Blanc, D
    Chazal, N
    Boulanger, P
    Sire, J
    Vigne, R
    Spire, B
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (12) : 9358 - 9365
  • [9] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA EXPRESSION BY 4 CHRONICALLY INFECTED CELL-LINES INDICATES MULTIPLE MECHANISMS OF LATENCY
    BUTERA, ST
    ROBERTS, BD
    LAM, L
    HODGE, T
    FOLKS, TM
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (04) : 2726 - 2730
  • [10] Characterization of human immunodeficiency virus type 1 Vif particle incorporation
    Camaur, D
    Trono, D
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (09) : 6106 - 6111